Lineage Newsroom

J.P. Morgan Downgrades Lineage(LINE.US) to Hold Rating, Cuts Target Price to $75

Futu NewsDec 21 02:43

J.P. Morgan Downgrades Lineage, Inc. (LINE) to a Hold

TipRanksDec 21 02:21

Lineage Cut to Neutral From Overweight by JP Morgan

Dow JonesDec 20 20:26

JP Morgan Downgrades Lineage to Neutral, Lowers Price Target to $75

BenzingaDec 20 20:17

Lineage Analyst Ratings

BenzingaDec 20 20:16

Truist Financial Maintains Lineage(LINE.US) With Buy Rating, Cuts Target Price to $80

Futu NewsDec 16 20:31

Truist Financial Sticks to Their Buy Rating for Lineage, Inc. (LINE)

TipRanksDec 16 19:59

Scotiabank Maintains Lineage(LINE.US) With Buy Rating, Cuts Target Price to $76

Futu NewsDec 10 23:31

Lineage Is Maintained at Sector Outperform by Scotiabank

Dow JonesDec 10 21:32

Lineage Analyst Ratings

BenzingaDec 10 21:22

Evercore Maintains Lineage(LINE.US) With Hold Rating, Cuts Target Price to $73

Futu NewsDec 9 21:33

Lineage, Inc. (LINE) Receives a Hold From Evercore ISI

TipRanksDec 9 21:14

Lineage Cell Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow JonesDec 4 19:26

J.P. Morgan Remains a Buy on Lineage, Inc. (LINE)

TipRanksNov 25 20:11

Lineage Cell Therapeutics Analyst Ratings

BenzingaNov 21 01:20

Wells Fargo Maintains Lineage(LINE.US) With Hold Rating

Futu NewsNov 19 16:41

Analysts Offer Insights on Healthcare Companies: Lineage Therap (LCTX), Veeva Systems (VEEV) and Takeda Pharmaceutical Company (TAK)

TipRanksNov 19 14:54

D. Boral Capital Initiates Coverage On Lineage Cell Therapeutics With Buy Rating, Announces Price Target of $3

BenzingaNov 18 23:13

Goldman Sachs Maintains Lineage(LINE.US) With Buy Rating, Cuts Target Price to $89

Futu NewsNov 14 07:31

Lineage Is Maintained at Outperform by RBC Capital

Dow JonesNov 13 23:17